|By PR Newswire||
|April 15, 2014 06:48 AM EDT||
DUBLIN, Apr. 15, 2014 /PRNewswire/ --
Research and Markets
) has announced the addition of the
report to their offering.
The analysts forecast the Global MicroRNA market to grow at a CAGR of 17.51 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in microRNA research funding. The Global MicroRNA market has also been witnessing the discovery and development of microRNAs as biomarkers for diseases. However, the high R&D costs could pose a challenge to the growth of this market.
The report, Global MicroRNA Market Report, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers North America, Europe, and the ROW; it also covers the Global MicroRNA market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
A biomarker is a substance or a molecular or cellular process or event that indicates a biological condition. Several research studies have confirmed that
have immense potential as biomarkers for a range of diseases, from cancer to cardiovascular diseases. An increasing number of vendors in the market are focusing on the discovery of microRNA biomarkers for diseases that do not as yet have defined microRNA biomarkers.
For instance, Biogen Idec Inc., a US-based biotechnology company focusing on the development of drugs for the Healthcare sector, and Regulus Therapeutics Inc., a US-based microRNA therapeutics company, have collaborated in their efforts to discover and develop microRNA biomarkers for multiple sclerosis. Thus, the Global MicroRNA market is witnessing the increasing use of microRNAs as biomarkers.
According to the report, one of the most important drivers is the increasing prevalence of diseases such as cancer, which has led to an increase in demand for microRNA-based diagnostic tests.
Key Topics Covered:
01. Executive Summary
02. Scope of the Report
03. Market Research Methodology
04. List of Abbreviations
06. Market Landscape
07. Global MicroRNA Research Market
08. Global MicroRNA Market
09. Global MicroRNA Market Segmentation
10. Geographical Segmentation
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
19. Key Vendor Analysis
20. Other Reports in this Series
- Access Pharmaceuticals
- Aegera Therapeutics Inc.
- Affymetrix Inc.
- Agilent Technologies
- Alnylam Pharmaceuticals Inc.
- Antisense Pharma GmbH
- Aparna Biosciences Corp.
- Applied Biological Materials Inc.
- Arrowhead Research Corp.
- AstraZeneca Pharmaceuticals LP
- Asuragen Inc.
- Benitec Biopharma Ltd.
- BioCancell Therapeutics Inc.
- Biogen Idec Inc.
- CBC Comprehensive Biomarker Center GmbH
- Clontech Laboratories Inc.
- Dicerna Pharmaceuticals Inc.
- Eli Lilly and Co.
- Exiqon A/S
- Expression Genetics Inc.
- F. Hoffman-La Roche AG
- Fluidigm Corp.
- GeneCopoeia Inc.
- GenoSensor Corp.
- Gensignia Inc.
- Groove Biopharma
- HTG Molecular Diagnostics Inc.
- Idera Pharmaceuticals Inc.
- Illumina Inc.
- InteRNA Technologies B.V.
- Isis Pharmaceuticals Inc.
- LC Sciences Llc
- Life Technologies Corp.
- Merck & Co. Inc.
- Mirna Therapeutics Inc.
- NanoString Technologies Inc.
- Norgen Biotek Corp.
- Novartis AG
- Pfizer Inc.
- Phalanx Biotech Group
- PhaseRx Inc.
- Prolias Technologies Inc.
- Qiagen N.V.
- Quark Pharmaceuticals Inc.
- RXi Pharmaceuticals Corp.
- Regulus Therapeutics Inc.
- Rosetta Genomics Ltd.
- Sanofi U.S.
- Santaris Pharma A/S.
- Sarepta Therapeutics
- Sigma-Aldrich Co. Llc
- Silence Therapeutics Plc
- Sirnaomics Inc.
- Sylentis SA
- Tacere Therapeutics Inc.
- Tekmira Pharmaceuticals Corp.
- Thermo Fisher Scientific Inc.
- WaferGen Biosystems Inc.
- miRagen Therapeutics Inc.
- siRNAsense AS
For more information visit http://www.researchandmarkets.com/research/6zn3pr/global_microrna
Media Contact: Laura Wood , +353-1-481-1716, [email protected]
SOURCE Research and Markets
Oct. 25, 2016 09:30 AM EDT Reads: 2,562
Oct. 25, 2016 09:15 AM EDT Reads: 1,062
Oct. 25, 2016 09:00 AM EDT Reads: 1,936
Oct. 25, 2016 08:45 AM EDT Reads: 16,496
Oct. 25, 2016 08:45 AM EDT Reads: 1,993
Oct. 25, 2016 08:30 AM EDT Reads: 890
Oct. 25, 2016 08:00 AM EDT Reads: 5,737
Oct. 25, 2016 07:45 AM EDT Reads: 4,905
Oct. 25, 2016 07:45 AM EDT Reads: 1,399
Oct. 25, 2016 06:45 AM EDT Reads: 4,823
Oct. 25, 2016 06:15 AM EDT Reads: 11,433
SYS-CON Events announced today that Interface Masters Technologies, a leader in Network Visibility and Uptime Solutions, will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Interface Masters Technologies is a leading vendor in the network monitoring and high speed networking markets. Based in the heart of Silicon Valley, Interface Masters' expertise lies in Gigabit, 10 Gigabit and 40 Gigabit Eth...
Oct. 25, 2016 05:45 AM EDT Reads: 3,353
We are reaching the end of the beginning with WebRTC, and real systems using this technology have begun to appear. One challenge that faces every WebRTC deployment (in some form or another) is identity management. For example, if you have an existing service – possibly built on a variety of different PaaS/SaaS offerings – and you want to add real-time communications you are faced with a challenge relating to user management, authentication, authorization, and validation. Service providers will w...
Oct. 25, 2016 05:30 AM EDT Reads: 3,376
As software becomes more and more complex, we, as software developers, have been splitting up our code into smaller and smaller components. This is also true for the environment in which we run our code: going from bare metal, to VMs to the modern-day Cloud Native world of containers, schedulers and microservices. While we have figured out how to run containerized applications in the cloud using schedulers, we've yet to come up with a good solution to bridge the gap between getting your conta...
Oct. 25, 2016 05:30 AM EDT Reads: 1,519
DevOps is being widely accepted (if not fully adopted) as essential in enterprise IT. But as Enterprise DevOps gains maturity, expands scope, and increases velocity, the need for data-driven decisions across teams becomes more acute. DevOps teams in any modern business must wrangle the ‘digital exhaust’ from the delivery toolchain, "pervasive" and "cognitive" computing, APIs and services, mobile devices and applications, the Internet of Things, and now even blockchain. In this power panel at @...
Oct. 25, 2016 05:15 AM EDT Reads: 1,997